Figures & data
Figure 1 Flowchart of EAP identification.
Abbreviations: COPD, chronic obstructive pulmonary disease; EAP, efficacy analyzable population; FEV1, forced expiratory volume in 1 second.
![Figure 1 Flowchart of EAP identification.](/cms/asset/554b2c1c-1638-4f70-ac00-ee9704d998d9/dcop_a_117652_f0001_b.jpg)
Table 1 Demographic data and FEV1 (%)
Figure 2 Proportion of the subjects with at least one exacerbation after 6 months of treatment.
![Figure 2 Proportion of the subjects with at least one exacerbation after 6 months of treatment.](/cms/asset/1890c057-fb78-42c9-b64f-8d80a9eed0ae/dcop_a_117652_f0002_c.jpg)
Figure 3 Cumulative numbers of exacerbations during the treatment period.
![Figure 3 Cumulative numbers of exacerbations during the treatment period.](/cms/asset/bc745967-ff36-47be-98f9-2f93728e3af3/dcop_a_117652_f0003_c.jpg)
Figure 4 Number of patients without clinical impairment of cough and sputum.
![Figure 4 Number of patients without clinical impairment of cough and sputum.](/cms/asset/a8f48f97-76a3-416f-a174-d39a32ad8754/dcop_a_117652_f0004_c.jpg)
Figure 5 Number of patients with a good or very good health status.
![Figure 5 Number of patients with a good or very good health status.](/cms/asset/1a7a7645-2cf1-4e48-afbe-796ac9a02d3a/dcop_a_117652_f0005_c.jpg)